Company Filing History:
2 out of 3,539 
1 out of 216 
1 out of 1 Years Active: 2014-2018
Title: Jens Habermann: Innovator in Cancer Diagnostics
Introduction
Jens Habermann is a notable inventor based in Celle, Germany. He has made significant contributions to the field of cancer diagnostics, holding a total of 3 patents. His work focuses on the identification of biomarkers that can aid in the diagnosis and treatment of cancer.
Latest Patents
One of Jens Habermann's latest patents is titled "Platelet biomarkers in cancer diagnosis." This invention relates to the use of platelet-derived biomarkers for diagnosing cancer and assessing cancer progression, as well as improving treatment options. Another significant patent is "Identification of biomarkers by serum protein profiling," which outlines methods for determining colorectal cancer status in a subject. This invention also includes kits designed for the same purpose, further enhancing the ability to identify biomarkers related to colorectal cancer.
Career Highlights
Throughout his career, Jens Habermann has worked with prestigious organizations, including the National Institutes of Health, a component of the US Department of Health & Human Services, and West Virginia University. His experience in these institutions has allowed him to contribute to groundbreaking research in cancer diagnostics.
Collaborations
Jens has collaborated with esteemed colleagues such as Gert Auer and Karl Thomas Ried. Their combined expertise has further advanced the field of cancer diagnostics.
Conclusion
Jens Habermann's innovative work in cancer diagnostics exemplifies the impact of research and invention in improving healthcare outcomes. His patents and collaborations highlight his commitment to advancing medical science.